OUR MISSION

Implementation of Innovative biophysical concept

We have developed a unique innovative biophysical concept, as well as the corresponding software, which allows us to represent biology not only as an exclusively experimental section of the natural sciences, but also to study this section from the point of view of the exact sciences. Thus, it will allow studying biology from the point of view of exact sciences.
Our main mission is to enable drug developers to use our innovative methodology to analyze the interactions of amino acid sequences before the experiment and then adjust the experimental problems.

There are four strategic areas to focus on: Alzheimer's disease, antibody-antigen comblex (EGFR proteins familie), peptides and proteins interactions, physics and mathematics basic research

Our goal is to create an adaptive database of pathological proteins that take part in cascading biochemical reactions, leading to various diseases, indicating their active centers, as well as the physical parameters of their inhibitors, binding sites, affinity, key amino acid residues, three-dimensional maps of energy interactions.


 Donate | World Cancer Research Fund International
Moreover, we want to share our method and teach people how to use methods by other laboratories around the world, as this will significantly accelerate the development of drugs against other diseases. Take the development of targeted drugs to a new level in the field of exact biochemistry.
You can contact us and reduce a lot of fail molecules in experiments for searching new molecules.At the moment, not a single company in the world has a methodology that would allow, within a couple of years, to select a wide range of inhibitors for all the desired pathological chemical reactions in the body, each of which is responsible for the development of a particular disease. We have ambitious tasks that require painstaking hard work. For each stage of database development, approximately 2 years are required, taking into account funding.
 Donate | World Cancer Research Fund International
The faster we can collect the necessary funding, the faster we can start and finish our goals, create and register a database of pathological inhibitors of cascading pathways of biochemical reactions leading to cancer or to Alzheimer's disease.
Donation

Advantages of ordering with us

Cost evaluation of antibody production, antibody based techniques, cost effective
Cost savings
Ordering work with us, you save almost 90% on preliminary screening experiments to find the most suitable immunoglobulins
 Industrialization of mAb production technology, Monoclonal Antibody (MAb) Manufacturing,cost-effective delivery of future antibody candidates,
Visibility
Three-dimensional map of the energy interaction of the amino acid sequences of an antibody with an antigen
Cost Effectiveness of Monoclonal Antibody Therapy, development has significant cost saving benefits,Development of Antibody-Based Therapeutics
No experiment needed
Determination of the affinity range for various substitutions of amino acid residues, during the formation of an antibody-antigen complex before an in vitro experiment
Current Trends in Monoclonal Antibody Development, antibodies are expected to be expensive, cost-effectiveness analysis is necessary to assess
Wide coverage
You do not have to be limited to a narrow list of substitutions of amino acid residues; instead, you get a wide range of possible modifications
cost reduction, monoclonal antibodies (mAbs) , Cost reduction can be achieved, monoclonal antibodies or recombinant proteins
Affinity range antibodies-antigen
The results obtained will determine the key amino acid residues that make the greatest changes in the affinity of the dimeric complex.
Efficiency
We take care about our clients time. Just contact us — and we will help you with all the questions.
Made on
Tilda